Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jan;61(1):65–68. doi: 10.1038/bjc.1990.14

Flow cytometric measurement of glutathione content of human cancer biopsies.

D W Hedley 1, A R Hallahan 1, E H Tripp 1
PMCID: PMC1971330  PMID: 2297492

Abstract

Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation between mean cell fluorescence, expressed as a ratio to that of fluorescence calibration beads, and biochemically determined GSH content over the range 0.2-2.0 fmol cell-1. Single cell suspensions from 14 human cancers were prepared by 23-gauge needle aspiration or mechanical disaggregation of surgical specimens, stained using mBCl and examined by flow cytometry. There was a wide range in individual cell fluorescence, which in contrast to EMT6 cells was not strongly correlated with Coulter volume. By comparing tumour cell fluorescence to that of calibration beads, and assuming that the relationship with GSH content for EMT6 holds for other cells, a mean GSH content of 0.95 fmol cell-1 was derived for nine carcinomas, and 0.21 fmol cell-1 for five non-Hodgkin's lymphomas. Although this semi-quantitation needs further validation, the method used here is rapid, gives an indication of heterogeneity of tumour cell GSH content, and can be applied to fine needle biopsy samples. It therefore shows promise as a means for studying prospectively the relationship of GSH content to clinical drug and radiation sensitivity, and for monitoring the effects of agents such as buthionine sulphoximine which are intended to improve treatment results through tumour cell GSH depletion.

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook J. A., Pass H. I., Russo A., Iype S., Mitchell J. B. Use of monochlorobimane for glutathione measurements in hamster and human tumor cell lines. Int J Radiat Oncol Biol Phys. 1989 May;16(5):1321–1324. doi: 10.1016/0360-3016(89)90307-6. [DOI] [PubMed] [Google Scholar]
  2. Deffie A. M., Alam T., Seneviratne C., Beenken S. W., Batra J. K., Shea T. C., Henner W. D., Goldenberg G. J. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res. 1988 Jul 1;48(13):3595–3602. [PubMed] [Google Scholar]
  3. Kramer R. A., Zakher J., Kim G. Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science. 1988 Aug 5;241(4866):694–697. doi: 10.1126/science.3399900. [DOI] [PubMed] [Google Scholar]
  4. Lee F. Y., Allalunis-Turner M. J., Siemann D. W. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine. Br J Cancer. 1987 Jul;56(1):33–38. doi: 10.1038/bjc.1987.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Meister A., Anderson M. E. Glutathione. Annu Rev Biochem. 1983;52:711–760. doi: 10.1146/annurev.bi.52.070183.003431. [DOI] [PubMed] [Google Scholar]
  6. O'Connor J. E., Kimler B. F., Morgan M. C., Tempas K. J. A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry. 1988 Nov;9(6):529–532. doi: 10.1002/cyto.990090604. [DOI] [PubMed] [Google Scholar]
  7. Ozols R. F., Louie K. G., Plowman J., Behrens B. C., Fine R. L., Dykes D., Hamilton T. C. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol. 1987 Jan 1;36(1):147–153. doi: 10.1016/0006-2952(87)90392-3. [DOI] [PubMed] [Google Scholar]
  8. Rice G. C., Bump E. A., Shrieve D. C., Lee W., Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res. 1986 Dec;46(12 Pt 1):6105–6110. [PubMed] [Google Scholar]
  9. Shrieve D. C., Bump E. A., Rice G. C. Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. J Biol Chem. 1988 Oct 5;263(28):14107–14114. [PubMed] [Google Scholar]
  10. Skapek S. X., Colvin O. M., Griffith O. W., Elion G. B., Bigner D. D., Friedman H. S. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Cancer Res. 1988 May 15;48(10):2764–2767. [PubMed] [Google Scholar]
  11. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969 Mar;27(3):502–522. doi: 10.1016/0003-2697(69)90064-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES